Could next-generation antimicrobial agents act as an alternative to standard antibiotics?

Next-generation antimicrobial agents (NGAs) as a potential alternative to standard antibiotics

Zealand’s GLP-1/GLP-2 drug bounces back with new Phase 1b data

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 10, 2024

David Baker, Demis Hassabis and John Jumper win chemistry Nobel for computational protein prediction and design

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 10, 2024

NIH Initiative on Psychedelic Therapy for Older Adults’ Chronic Pain

The TDR Three Key Takeaways regarding NIH Initiative on Psychedelic Therapy: Federal backing of psychedelic research marks a shift in policy. NIH to conduct extensive

April 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.